PrognomiQ: Joel Kaufman

Multiomics data firm PrognomiQ has appointed Joel Kaufman as its CFO. Most recently he was CFO of Haystack Oncology. Before that he was VP of financing and corporate development at Sema4, and before that he was chief business officer at Navidea Biopharmaceuticals and a research analyst at Goldman Sachs. PrognomiQ plans to launch an early cancer detection test in the first half of this year as a laboratory-developed test, it said. In November the company raised $34 million in a Series D financing round.